Upgrade to SI Premium - Free Trial

Oruka Therapeutics, Inc. (ORKA) Reports Q3 Loss of $1.46

November 13, 2024 6:01 PM

Oruka Therapeutics, Inc. (NASDAQ: ORKA) reported Q3 EPS of ($1.46).

For earnings history and earnings-related data on Oruka Therapeutics, Inc. (ORKA) click here.

Categories

Earnings